vs

Side-by-side financial comparison of Cintas (CTAS) and Eastman Chemical Company (EMN). Click either name above to swap in a different company.

Cintas is the larger business by last-quarter revenue ($6.4B vs $2.0B, roughly 3.3× Eastman Chemical Company). Cintas runs the higher net margin — 7.8% vs 5.3%, a 2.5% gap on every dollar of revenue. On growth, Cintas posted the faster year-over-year revenue change (8.9% vs -13.8%). Over the past eight quarters, Cintas's revenue compounded faster (61.2% CAGR vs -8.6%).

Cintas Corporation is an American corporation headquartered in Mason, Ohio, which provides a range of products and services to businesses including uniforms, mats, mops, cleaning and restroom supplies, first aid and safety products, fire extinguishers and testing, and safety courses. Cintas is a publicly held company traded on the Nasdaq Global Select Market under the symbol CTAS and is a component of the S&P 500 Index.

Eastman Chemical Company is an American chemical products manufacturer based in Kingsport, Tennessee. Founded in 1920, it was formerly a subsidiary of Kodak until 1994. The company is an independent global specialty materials company that produces a broad range of advanced materials, chemicals and fibers for everyday purposes. It operates 36 manufacturing sites worldwide and employs approximately 14,000 people. In 2023, Eastman had sales revenue of approximately $9.21 billion.

CTAS vs EMN — Head-to-Head

Bigger by revenue
CTAS
CTAS
3.3× larger
CTAS
$6.4B
$2.0B
EMN
Growing faster (revenue YoY)
CTAS
CTAS
+22.7% gap
CTAS
8.9%
-13.8%
EMN
Higher net margin
CTAS
CTAS
2.5% more per $
CTAS
7.8%
5.3%
EMN
Faster 2-yr revenue CAGR
CTAS
CTAS
Annualised
CTAS
61.2%
-8.6%
EMN

Income Statement — Q4 FY2026 vs Q1 FY2026

Metric
CTAS
CTAS
EMN
EMN
Revenue
$6.4B
$2.0B
Net Profit
$502.5M
$105.0M
Gross Margin
83.1%
17.1%
Operating Margin
10.3%
Net Margin
7.8%
5.3%
Revenue YoY
8.9%
-13.8%
Net Profit YoY
8.4%
-42.3%
EPS (diluted)
$1.24
$0.93

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTAS
CTAS
EMN
EMN
Q1 26
$6.4B
$2.0B
Q4 25
$2.8B
$2.0B
Q3 25
$2.7B
$2.2B
Q2 25
$2.7B
$2.3B
Q1 25
$2.6B
$2.3B
Q4 24
$2.6B
$2.2B
Q3 24
$2.5B
$2.5B
Q2 24
$2.5B
$2.4B
Net Profit
CTAS
CTAS
EMN
EMN
Q1 26
$502.5M
$105.0M
Q4 25
$495.3M
$105.0M
Q3 25
$491.1M
$47.0M
Q2 25
$448.3M
$140.0M
Q1 25
$463.5M
$182.0M
Q4 24
$448.5M
$330.0M
Q3 24
$452.0M
$180.0M
Q2 24
$414.3M
$230.0M
Gross Margin
CTAS
CTAS
EMN
EMN
Q1 26
83.1%
17.1%
Q4 25
50.4%
17.1%
Q3 25
50.3%
19.7%
Q2 25
49.7%
22.1%
Q1 25
50.6%
24.8%
Q4 24
49.8%
24.7%
Q3 24
50.1%
24.6%
Q2 24
25.3%
Operating Margin
CTAS
CTAS
EMN
EMN
Q1 26
10.3%
Q4 25
23.4%
0.6%
Q3 25
22.7%
6.1%
Q2 25
22.4%
7.4%
Q1 25
23.4%
11.0%
Q4 24
23.1%
13.2%
Q3 24
22.4%
11.4%
Q2 24
22.2%
12.1%
Net Margin
CTAS
CTAS
EMN
EMN
Q1 26
7.8%
5.3%
Q4 25
17.7%
5.3%
Q3 25
18.1%
2.1%
Q2 25
16.8%
6.1%
Q1 25
17.8%
7.9%
Q4 24
17.5%
14.7%
Q3 24
18.1%
7.3%
Q2 24
16.8%
9.7%
EPS (diluted)
CTAS
CTAS
EMN
EMN
Q1 26
$1.24
$0.93
Q4 25
$1.21
$0.93
Q3 25
$1.20
$0.40
Q2 25
$1.08
$1.20
Q1 25
$1.13
$1.57
Q4 24
$1.09
$2.81
Q3 24
$1.10
$1.53
Q2 24
$4.00
$1.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTAS
CTAS
EMN
EMN
Cash + ST InvestmentsLiquidity on hand
$183.2M
$566.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.8B
$6.0B
Total Assets
$14.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTAS
CTAS
EMN
EMN
Q1 26
$183.2M
$566.0M
Q4 25
$200.8M
$566.0M
Q3 25
$138.1M
Q2 25
$264.0M
Q1 25
$243.4M
Q4 24
$122.4M
$837.0M
Q3 24
$101.4M
Q2 24
$342.0M
Total Debt
CTAS
CTAS
EMN
EMN
Q1 26
Q4 25
$2.4B
Q3 25
$2.4B
Q2 25
$2.4B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$2.0B
Stockholders' Equity
CTAS
CTAS
EMN
EMN
Q1 26
$4.8B
$6.0B
Q4 25
$4.5B
$6.0B
Q3 25
$4.8B
$5.8B
Q2 25
$4.7B
$5.8B
Q1 25
$4.6B
$5.9B
Q4 24
$4.3B
$5.8B
Q3 24
$4.0B
$5.7B
Q2 24
$4.3B
$5.6B
Total Assets
CTAS
CTAS
EMN
EMN
Q1 26
$14.9B
Q4 25
$10.1B
$14.9B
Q3 25
$9.8B
$15.0B
Q2 25
$9.8B
$15.2B
Q1 25
$9.6B
$15.0B
Q4 24
$9.4B
$15.2B
Q3 24
$9.1B
$15.1B
Q2 24
$9.2B
$14.9B
Debt / Equity
CTAS
CTAS
EMN
EMN
Q1 26
Q4 25
0.54×
Q3 25
0.51×
Q2 25
0.52×
Q1 25
0.44×
Q4 24
0.47×
Q3 24
0.50×
Q2 24
0.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTAS
CTAS
EMN
EMN
Operating Cash FlowLast quarter
$1.6B
Free Cash FlowOCF − Capex
$1.3B
FCF MarginFCF / Revenue
19.7%
Capex IntensityCapex / Revenue
4.7%
Cash ConversionOCF / Net Profit
3.12×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTAS
CTAS
EMN
EMN
Q1 26
$1.6B
Q4 25
$531.2M
$502.0M
Q3 25
$414.5M
$402.0M
Q2 25
$635.7M
$233.0M
Q1 25
$622.0M
$-167.0M
Q4 24
$441.4M
$540.0M
Q3 24
$466.7M
$396.0M
Q2 24
$693.0M
$367.0M
Free Cash Flow
CTAS
CTAS
EMN
EMN
Q1 26
$1.3B
Q4 25
$425.0M
$390.0M
Q3 25
$312.5M
$265.0M
Q2 25
$521.1M
$83.0M
Q1 25
$522.1M
$-314.0M
Q4 24
$340.0M
$361.0M
Q3 24
$373.8M
$276.0M
Q2 24
$591.1M
$252.0M
FCF Margin
CTAS
CTAS
EMN
EMN
Q1 26
19.7%
Q4 25
15.2%
19.8%
Q3 25
11.5%
12.0%
Q2 25
19.5%
3.6%
Q1 25
20.0%
-13.7%
Q4 24
13.3%
16.1%
Q3 24
14.9%
11.2%
Q2 24
23.9%
10.7%
Capex Intensity
CTAS
CTAS
EMN
EMN
Q1 26
4.7%
Q4 25
3.8%
5.7%
Q3 25
3.8%
6.2%
Q2 25
4.3%
6.6%
Q1 25
3.8%
6.4%
Q4 24
4.0%
8.0%
Q3 24
3.7%
4.9%
Q2 24
4.1%
4.9%
Cash Conversion
CTAS
CTAS
EMN
EMN
Q1 26
3.12×
Q4 25
1.07×
4.78×
Q3 25
0.84×
8.55×
Q2 25
1.42×
1.66×
Q1 25
1.34×
-0.92×
Q4 24
0.98×
1.64×
Q3 24
1.03×
2.20×
Q2 24
1.67×
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons